EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Alpha‐1 antitrypsin deficiency associated with increased risks of skin cancer, leukemia, and hepatic cancer: A nationwide cohort study

Nanna J Korsbæk, Eskild M Landt, Sarah C W Marott, Børge G Nordestgaard iD, Gabrielle R Vinding, Gregor B E Jemec, Morten Dahl

Journal of Internal Medicine · 2024

DOI: 10.1111/joim.20016 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Internal Medicine, 2024. Verfasst von Nanna J Korsbæk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Zealand University Hospital, Køge, Denmark. Hauptthemen laut MEDLINE: Liver Neoplasms, alpha 1-Antitrypsin Deficiency, Leukemia, Skin Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Sjælland, Alpha-1 Foundation, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background α 1 ‐Antitrypsin deficiency is characterized by elevated elastase activity and excessive elastin degradation, which may impact cancer development and progression. We tested the hypothesis that individuals with α 1 ‐antitrypsin deficiency have increased susceptibility to cancer in the Danish population.

Methods

In a nationwide nested study, we identified 2702 individuals with α 1 ‐antitrypsin deficiency and 26,750 control subjects without α 1 ‐antitrypsin deficiency matched on age, sex, and municipality. We recorded admissions due to cancer as outcomes during a median follow‐up of 62 years.

Results

Individuals with α 1 ‐antitrypsin deficiency versus control subjects had an increased hazard of skin cancer (2.18, 95%CI: 1.81–2.63), leukemia (1.76, 1.12–2.79), liver cancer (3.91, 2.23–6.85), and cancer overall (1.25, 1.13–1.38). Corresponding hazard ratios when the entire Danish population was used as control group were 3.02 (2.55–3.58), 1.83 (1.19–2.81), 4.46 (2.74–7.28), and 1.45 (1.31–1.59). When the analysis was stratified according to comorbidities, the hazard for skin cancer was higher in those with chronic obstructive pulmonary disease (COPD) (3.59, 2.60–4.95) and skin disease (2.93, 2.19–3.92) but remained elevated in those without any of these diseases. Hazards for skin cancer in individuals with α 1 ‐antitrypsin deficiency were similar when stratified by liver cirrhosis and ischemic heart disease ( p s for interaction: ≥0.76). Hazards for liver cancer in individuals with α 1 ‐antitrypsin deficiency versus control subjects were similar when stratified according to liver cirrhosis, COPD, skin disease, and ischemic heart disease ( p s for interaction: ≥0.13).

Conclusion

Individuals with α 1 ‐antitrypsin deficiency have increased risks of skin cancer, leukemia, and liver cancer in the Danish population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Neoplasmsalpha 1-Antitrypsin DeficiencyLeukemiaSkin NeoplasmsHumansMaleFemaleDenmarkMiddle AgedAdultAgedRisk FactorsCohort StudiesCase-Control Studies

Stichwörter der Autor:innen

SERPINA1hepatic cancerleukemiaprognosisskin cancerα1‐antitrypsin deficiency

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Zealand University Hospital, Køge, Denmark.
  • Department of Clinical Medicine, Faculty of Health & Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev Gentofte Hospital, Herlev, Denmark.
  • Copenhagen General Population Study, Copenhagen University Hospital, Herlev Gentofte Hospital, Herlev, Denmark.
  • Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.

ORCID-Profile: Børge G Nordestgaard

Förderung

  • Region Sjælland
  • Alpha-1 Foundation
  • Novo Nordisk Fonden

Zitieren

APA

Korsbæk, N. J., Landt, E. M., Marott, S. C. W., Nordestgaard, B. G., Vinding, G. R., Jemec, G. B. E., & Dahl, M. (2024). Alpha‐1 antitrypsin deficiency associated with increased risks of skin cancer, leukemia, and hepatic cancer: A nationwide cohort study. Journal of Internal Medicine. https://doi.org/10.1111/joim.20016

Vancouver

Korsbæk NJ, Landt EM, Marott SCW, Nordestgaard BG, Vinding GR, Jemec GBE, et al. Alpha‐1 antitrypsin deficiency associated with increased risks of skin cancer, leukemia, and hepatic cancer: A nationwide cohort study. Journal of Internal Medicine. 2024. doi:10.1111/joim.20016

BibTeX
@article{Korsbk2024,
  author = {Korsbæk, Nanna J and Landt, Eskild M and Marott, Sarah C W and Nordestgaard, Børge G and Vinding, Gabrielle R and Jemec, Gregor B E and Dahl, Morten},
  title = {Alpha‐1 antitrypsin deficiency associated with increased risks of skin cancer, leukemia, and hepatic cancer: A nationwide cohort study},
  journal = {Journal of Internal Medicine},
  year = {2024},
  doi = {10.1111/joim.20016}
}
Kostenlos starten →